206 related articles for article (PubMed ID: 36549515)
1. Effect of chemotherapy, immunotherapy, and targeted therapies on removal of indwelling pleural catheters in non-small cell lung cancer patients with malignant pleural effusions.
Wang M; Sparrow K; Chan C; Gillson A; Stollery D; Li P
Respir Med; 2023 Jan; 206():107093. PubMed ID: 36549515
[TBL] [Abstract][Full Text] [Related]
2. Clinical Predictors of Successful and Earlier Removal of Indwelling Pleural Catheters in Benign Pleural Effusions.
Li P; Hosseini S; Zhang T; Amjadi K
Respiration; 2019; 98(3):239-245. PubMed ID: 31266047
[TBL] [Abstract][Full Text] [Related]
3. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial.
Davies HE; Mishra EK; Kahan BC; Wrightson JM; Stanton AE; Guhan A; Davies CW; Grayez J; Harrison R; Prasad A; Crosthwaite N; Lee YC; Davies RJ; Miller RF; Rahman NM
JAMA; 2012 Jun; 307(22):2383-9. PubMed ID: 22610520
[TBL] [Abstract][Full Text] [Related]
4. Management of malignant pleural effusions with indwelling pleural catheters or talc pleurodesis.
Srour N; Amjadi K; Forster A; Aaron S
Can Respir J; 2013; 20(2):106-10. PubMed ID: 23616967
[TBL] [Abstract][Full Text] [Related]
5. The use of indwelling pleural catheters for the treatment of malignant pleural effusions.
Syer T; Walker S; Maskell N
Expert Rev Respir Med; 2019 Jul; 13(7):659-664. PubMed ID: 31177915
[No Abstract] [Full Text] [Related]
6. Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters.
Azzopardi M; Thomas R; Muruganandan S; Lam DC; Garske LA; Kwan BC; Rashid Ali MR; Nguyen PT; Yap E; Horwood FC; Ritchie AJ; Bint M; Tobin CL; Shrestha R; Piccolo F; De Chaneet CC; Creaney J; Newton RU; Hendrie D; Murray K; Read CA; Feller-Kopman D; Maskell NA; Lee YC
BMJ Open; 2016 Jul; 6(7):e011480. PubMed ID: 27381209
[TBL] [Abstract][Full Text] [Related]
7. Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion.
Fitzgerald DB; Sidhu C; Budgeon C; Tan AL; Read CA; Kwan BCH; Smith NA; Fysh ET; Muruganandan S; Saghaie T; Shrestha R; Badiei A; Nguyen P; Burke A; Goddard J; Windsor M; McDonald J; Wright G; Czarnecka K; Sivakumar P; Yasufuku K; Feller-Kopman DJ; Maskell NA; Murray K; Lee YCG
Trials; 2022 Jun; 23(1):530. PubMed ID: 35761341
[TBL] [Abstract][Full Text] [Related]
8. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Dipper A; Jones HE; Bhatnagar R; Preston NJ; Maskell N; Clive AO
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010529. PubMed ID: 32315458
[TBL] [Abstract][Full Text] [Related]
9. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.
Fysh ETH; Waterer GW; Kendall PA; Bremner PR; Dina S; Geelhoed E; McCarney K; Morey S; Millward M; Musk AWB; Lee YCG
Chest; 2012 Aug; 142(2):394-400. PubMed ID: 22406960
[TBL] [Abstract][Full Text] [Related]
10. The Hospital and Patient Burden of Indwelling Pleural Catheters: A Retrospective Case Series of 210 Indwelling Pleural Catheter Insertions.
Asciak R; Hallifax RJ; Mercer RM; Hassan M; Wigston C; Wrightson JM; Psallidas I; Rahman NM
Respiration; 2019; 97(1):70-77. PubMed ID: 30227409
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).
Boshuizen RC; Vd Noort V; Burgers JA; Herder GJM; Hashemi SMS; Hiltermann TJN; Kunst PW; Stigt JA; van den Heuvel MM
Lung Cancer; 2017 Jun; 108():9-14. PubMed ID: 28625655
[TBL] [Abstract][Full Text] [Related]
12. Protocol of the Australasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesis.
Fysh ET; Thomas R; Read CA; Kwan BC; Yap E; Horwood FC; Lee P; Piccolo F; Shrestha R; Garske LA; Lam DC; Rosenstengel A; Bint M; Murray K; Smith NA; Lee YC
BMJ Open; 2014 Nov; 4(11):e006757. PubMed ID: 25377015
[TBL] [Abstract][Full Text] [Related]
13. Silver Nitrate-coated versus Standard Indwelling Pleural Catheter for Malignant Effusions: The SWIFT Randomized Trial.
Shrager JB; Bhatnagar R; Kearney CT; Retzlaff NP; Cohen E; Stanton AE; Keyes C; Wahidi MM; Gillespie C; Rahman N; Kerry AL; Feller-Kopman D; Nader D; Akulian J; Chen A; Berry M; Majid A; Reddy C; Tremblay A; Maskell NA
Ann Am Thorac Soc; 2022 Oct; 19(10):1722-1729. PubMed ID: 35363591
[No Abstract] [Full Text] [Related]
14. The Impact of Anticoagulation on Indwelling Pleural Catheter Removal due to Pleurodesis in Patients with Malignant Pleural Effusion.
Tellez Garcia E; Ost D; Grosu HB
Respiration; 2023; 102(4):308-315. PubMed ID: 36720213
[TBL] [Abstract][Full Text] [Related]
15. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
Thomas R; Fysh ETH; Smith NA; Lee P; Kwan BCH; Yap E; Horwood FC; Piccolo F; Lam DCL; Garske LA; Shrestha R; Kosky C; Read CA; Murray K; Lee YCG
JAMA; 2017 Nov; 318(19):1903-1912. PubMed ID: 29164255
[TBL] [Abstract][Full Text] [Related]
16. Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial.
Muruganandan S; Azzopardi M; Fitzgerald DB; Shrestha R; Kwan BCH; Lam DCL; De Chaneet CC; Rashid Ali MRS; Yap E; Tobin CL; Garske LA; Nguyen PT; Stanley C; Popowicz ND; Kosky C; Thomas R; Read CA; Budgeon CA; Feller-Kopman D; Maskell NA; Murray K; Lee YCG
Lancet Respir Med; 2018 Sep; 6(9):671-680. PubMed ID: 30037711
[TBL] [Abstract][Full Text] [Related]
17. Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis.
Yeung M; Loh EW; Tiong TY; Tam KW
Clin Exp Metastasis; 2020 Aug; 37(4):541-549. PubMed ID: 32524317
[TBL] [Abstract][Full Text] [Related]
18. Effect of Chemotherapy on Removal of Indwelling Pleural Catheters in Breast Cancer Patients with Malignant Pleural Effusions.
Mitchell MA; Burkett A; Li P; Zhang T; Amjadi K
Respiration; 2018; 96(6):552-559. PubMed ID: 30205402
[TBL] [Abstract][Full Text] [Related]
19. Comparing cost of indwelling pleural catheter vs talc pleurodesis for malignant pleural effusion.
Penz ED; Mishra EK; Davies HE; Manns BJ; Miller RF; Rahman NM
Chest; 2014 Oct; 146(4):991-1000. PubMed ID: 24832000
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of indwelling pleural catheter placement versus placement plus talc sclerosant in patients with malignant pleural effusions managed exclusively as outpatients (IPC-PLUS): study protocol for a randomised controlled trial.
Bhatnagar R; Kahan BC; Morley AJ; Keenan EK; Miller RF; Rahman NM; Maskell NA
Trials; 2015 Feb; 16():48. PubMed ID: 25880969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
